BRAWLEY OTIS W

LYEL

BRAWLEY OTIS W serves as Director at Lyell Immunopharma, Inc. (LYEL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$20.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$20.0K

Companies Traded

LYEL

Active Period

Mar 2025

1 total trades

Most Recent

Buy LYEL

Mar 31, 2025 · $20.0K

BRAWLEY OTIS W's Insider Trading at Lyell Immunopharma, Inc. (LYEL)

Buys

1 · $20.0K

Sells

0 · $0.00

Total Shares Bought

35,640

Total Shares Sold

LYEL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 31, 2025↗	Buy	35,640	$0.56	$20.0K	0

Related Insiders

Venture Fund XIII, L.P. ARCH

10 percent owner

LYELBuy · Mar 6, 2026

Venture Partners IX, LLC ARCH

10 percent owner

LYELBuy · Mar 6, 2026

Lynn Seely

President and CEO

LYELSell · Feb 11, 2026

Stephen J. Hill

Chief Operating Officer

LYELSell · Feb 11, 2026

Stephen J. Hill

officer: Chief Operating Officer

LYELSell · Feb 11, 2026

Gary K. Lee

Chief Scientific Officer

LYELSell · Feb 11, 2026

Gary K. Lee

officer: Chief Scientific Officer

LYELSell · Feb 11, 2026

Lynn Seely

director, officer: President and CEO

LYELSell · Feb 11, 2026

Explore More Insider Trading Data

LYEL Insider Trading Activity

View all insider trades at Lyell Immunopharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity